BDNF and depressive disorder: The induction of oxidative stress, reduction of BDNF and serotonin, and attenuation of CREB signaling by prenatal exposure to a supra-therapeutic dose of buprenorphine provides evidence of a potential mechanism for the development of depression-like neurobehaviors.